These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 24862102)

  • 1. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
    Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
    J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
    Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
    Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
    Ligor T; Pater Ł; Buszewski B
    J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lung cancer breath signature: a comparative analysis of exhaled breath and air sampled from inside the lungs.
    Capuano R; Santonico M; Pennazza G; Ghezzi S; Martinelli E; Roscioni C; Lucantoni G; Galluccio G; Paolesse R; Di Natale C; D'Amico A
    Sci Rep; 2015 Nov; 5():16491. PubMed ID: 26559776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants.
    Filipiak W; Ruzsanyi V; Mochalski P; Filipiak A; Bajtarevic A; Ager C; Denz H; Hilbe W; Jamnig H; Hackl M; Dzien A; Amann A
    J Breath Res; 2012 Sep; 6(3):036008. PubMed ID: 22932429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.
    Ligor M; Ligor T; Bajtarevic A; Ager C; Pienz M; Klieber M; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Buszewski B; Miekisch W; Schubert J; Amann A
    Clin Chem Lab Med; 2009; 47(5):550-60. PubMed ID: 19397483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
    Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
    Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
    Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Searching for selected VOCs in human breath samples as potential markers of lung cancer.
    Rudnicka J; Kowalkowski T; Buszewski B
    Lung Cancer; 2019 Sep; 135():123-129. PubMed ID: 31446984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns.
    Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y
    Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders.
    Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H
    J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation.
    Wang C; Dong R; Wang X; Lian A; Chi C; Ke C; Guo L; Liu S; Zhao W; Xu G; Li E
    Sci Rep; 2014 Dec; 4():7312. PubMed ID: 25482491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of exhaled volatile organic compounds in lung cancer patients].
    Lu CR; Hu YJ; Chen EG; Qiu YH; Ying KJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):104-8. PubMed ID: 20367949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.
    Sponring A; Filipiak W; Mikoviny T; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
    Anticancer Res; 2009 Jan; 29(1):419-26. PubMed ID: 19331181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.